Rationale for New American Diabetes Association Guidelines: Are National Cholesterol Education Program Goals Adequate for the Patient with Diabetes Mellitus?
- 22 August 2005
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 96 (4) , 33-36
- https://doi.org/10.1016/j.amjcard.2005.05.012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final ReportCirculation, 2002
- Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 DiabetesDiabetes Care, 2002
- Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose LevelsArchives of internal medicine (1960), 1999
- Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol LevelsCirculation, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)BMJ, 1998
- Cardiovascular Risk Factors in Confirmed Prediabetic IndividualsJAMA, 1990
- Diabetes and Cardiovascular DiseaseJAMA, 1979